Skip to main content

Securities Law Prof Blog

Caremark-CVS Developments

By Securites Lawprof

New developments in the unpopular Caremark-CVS merger — CVS increased its bid by increasing the special  cash dividend component.  Its price for a Caremark share, valued at 60.26, is still less than rival Express Scripts’ bid of 61.08 and the current market price.  In addition, the Delaware court postponed the shareholder meeting scheduled to vote on the merger until next month.   The Chancellor questioned Caremark’s insistence that it can’t speak to Express Scripts because of antitrust issues. See NY Times,  CVS Raises Its Bid for Caremark Rx as Judge Delays Vote and WSJ, Judge Delays Caremark Vote.

Originally published at lawprofessors.typepad.com

Citation

Securites Lawprof, Caremark-CVS Developments, Securities Law Prof Blog (February 14, 2007) [The Library at LexBlog, LEX-WK-ZC13PBDX, lexpid.org/ZC13PBDX]

View the record

Filed under